Canada markets closed

Anebulo Pharmaceuticals, Inc. (214.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
2.76000.0000 (0.00%)
At close: 03:29PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in USD. All numbers in thousands
Breakdown
ttm
2023-06-30
2022-06-30
2021-06-30
Total Revenue
0
0
0
0
Operating Expenses
Research Development
4,498
5,600
2,962
2,270
Selling General and Administrative
4,964
6,183
3,870
1,344
Total Operating Expenses
9,463
11,784
6,831
3,614
Operating Income or Loss
-9,463
-11,784
-6,831
-3,614
Interest Expense
-
-
0
11.767
Total Other Income/Expenses Net
8.187
-41.146
-1.777
-26,628
Income Before Tax
-9,347
-11,732
-6,826
-30,253
Income from Continuing Operations
-9,347
-11,732
-6,826
-30,253
Net Income
-9,347
-11,732
-6,826
-30,253
Net Income available to common shareholders
-9,347
-11,732
-6,826
-38,461
Basic EPS
-0.46
-0.47
-0.29
-2.83
Diluted EPS
-0.46
-0.47
-0.29
-2.83
Basic Average Shares
25,629
25,074
23,345
13,613
Diluted Average Shares
25,629
25,074
23,345
13,613